-
Dr. Janet Conway performs 1st case with Cerament G bone graft
Janet Conway, MD, completed the first U.S. cases using Bonesupport's Cerament G for osteomyelitis. -
Ossio closes $38.5M financing
Orthobiologics company Ossio closed a $38.5 million series C financing round. -
6 updates in orthobiologics
Here are six key updates in regenerative medicine since Oct. 1: -
Dr. Alan Daniels debuts Orthofix's new demineralized bone matrix
Orthofix launched its Legacy demineralized bone matrix, and Alan Daniels, MD, performed the first case with it. -
ChitogenX launches 2nd orthopedic development program for meniscus repair
ChitogenX launched its second orthopedic development program in meniscus repair, the orthobiologics company said Oct. 13. -
Aziyo Biologics adds to leadership team
Aziyo Biologics promoted leadership and added new hires on its team, the company said Oct. 11. -
Orthobiologics company Cerapedics appoints new CEO
Westminster, Colo.-based orthobiologics company Cerapedics has appointed Valeska Schroeder as its new CEO, effective Nov. 1. -
1st stem cell treatment for spina bifida performed during fetal surgery
Three babies have been born after UC Davis Health providers performed the first spina bifida treatment combining surgery with stem cells. -
Orthobiologics company goes public
Bone Biologics, which focuses on spinal orthobiologics, announced its underwritten public offering for $5.1 million total. -
Precision Spine, HippoFi enters partnership to boost biologics sales
Precision Spine and HippoFi inked an agreement to help drive the sales of Pur Biologics products. -
Dr. James Andrews, Celltex Therapeutics partner to form biologics company
Pensacola, Fla.-based Andrews Medicine, led by James Andrews, MD, is partnering with Houston-based Celltex Therapeutics to form a biotechnology company focused on stem cell research and sports medicine. -
8 key developments in orthopedic biologics in Q3
From executive leadership moves to new product developments, here are key headlines about orthopedic regenerative medicine from the third quarter: -
Spinal bone marrow injections effective for lower back pain 2 years post-op, study finds
A two-year study found Creative Medical Technology's StemSpine procedure was effective for treating lower back pain, the biologics company said Sept. 26. -
Bioinductive implant reduces rotator cuff retear rates 86%: study
A randomized controlled trial found Smith+Nephew's Regeneten bioinductive implant is effective at preventing retearing after a rotator cuff repair. -
FDA approves Ventris Medical's standalone bone graft putty
Ventris Medical's Amplify synthetic bone graft putty earned FDA 510(k) clearance. -
Ortho Regenerative Technologies changes name
Ortho Regenerative Technologies is now called ChitogenX, the company said Sept. 7. -
7 updates in regenerative medicine
From CEO moves to product debuts, here are seven developments from regenerative medicine companies since July 22. -
Aziyo Biologics names chief scientific officer
Aziyo Biologics named Michelle Williams, PhD, as chief scientist, the regenerative medicine company said Aug. 26. -
Dr. Cesar Ceballos debuts ACL restoration implant in Miami
Cesar Ceballos, MD, founder of OrthoMiami, performed Miami's first BEAR procedure — a case involving a 19-year-old patient. -
Scripps Clinic adds ACL restoration procedure
Scripps Clinic in San Diego added the BEAR biologic implant for ACL restoration, CBS affiliate KFMB reported Aug. 23.
Page 6 of 36